Please assess the completion status of the following clinical trial:

Trial Title: The Gore SCAFFOLD Clinical Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is at least 18 years old at informed consent~* Patient is willing and capable of complying with all study protocol requirements, including specified follow-up period and can be contacted by telephone.~* Patient is willing to provide written informed consent prior to enrollment in study.~* Patient is either:~  * Symptomatic with carotid stenosis ≥50% as determined by angiography using NASCET methodology. Symptomatic is defined as amaurosis fugax ipsilateral to the carotid lesion; Transient Ischemic Attack (TIA) or non-disabling stroke within 180 days of the procedure within the hemisphere supplied by the target vessel; OR~ * Asymptomatic with carotid stenosis ≥80% as determined by angiography using NASCET methodology~* Patient must be considered high risk for adverse events during carotid endarterectomy~Note: Additional inclusion criteria may apply~Exclusion Criteria:~* Patient has life expectancy of less than one year.~* Patient is experiencing (or has experienced) an evolving, acute, or recent disabling stroke.~* Patient has anticipated or potential sources of emboli (e.g. atrial fibrillation, known previously symptomatic patent foramen ovale (PFO), mechanical heart valve, or Deep Vein Thrombosis (DVT) treated within 6 months).~* Patient has had an acute myocardial infarction within 72 hours prior to the index procedure.~* Patient has a history of major, disabling ipsilateral stroke with residual deficit that may confound the neurological subject assessments.~* Patient has known severe carotid stenosis contralateral to the target lesion requiring treatment within 30 days following the index procedure.~Note: Additional exclusion criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Carotid Artery Stenting (Type: EXPERIMENTAL): Carotid Artery Stenting with the GORE® Carotid Stent

Based on this trial design, predict the completion outcome and termination type (if applicable).